Previous 10 | Next 10 |
Summary Among healthcare stocks, Eagle Pharmaceuticals is an interesting opportunity to benefit from volatility in stock markets. Eagle Pharmaceuticals' product portfolio continues to perform well and has the potential to strengthen its position in the market through new treatment devel...
Summary Even in its battered condition, the therapeutics sub-sector still accounts for 9.1% of the Russell 2000 Growth index. M&A activity continues to heat up as big players—currently flush with cash—look to drive growth by filling their development pipelines. In ...
Summary TACK is a tactical ETF that holds sector funds. It also may give exposure to T-bills and gold in bad markets. TACK gets my approval as a dynamic strategy that works hard to protect investor capital. Fairlead Tactical Sector ETF ( TACK ) is a dynamic strategy to...
Summary DNP is a utilities equities closed end fund with a substantial track record. The fund is one of those rare, golden standard CEFs that have always traded at premiums to NAV in the past decade. With the entire Utilities sector trading at historic high P/E ratios on the back of...
Summary Last year’s market volatility was driven primarily by uncertainty over inflation and interest rates. In last year’s downturn, technology stocks were at the epicenter of market volatility. After years of steady gains, investors now acknowledge that technology stocks...
Summary Pharmaceuticals and biotechnology have the best value and quality scores in the sector. Healthcare providers are close to their historical baseline in valuation and quality. Fast facts on GNOM. 10 stocks cheaper than their peers in January. This monthly article...
Summary QQQ and the S&P 500 have dropped from all-time record overvaluations a year ago but are still trading at more than double their average ratios relative to the profits of their components. Real estate has fallen modestly from its all-time highs in recent months but is about 7...
Summary The health care sector - as measured by the Fidelity Health Care ETF - outperformed the S&P 500 by ~12.2% over the past year. That's because health care is considered to be a relatively defensive sector due to the fact that healthcare - in general - cannot be delayed, no mat...
Summary Vera’s phase 2b ORIGIN data was underwhelming with lower than expected proteinuria reduction ~31% even at 9 months. We believe Atacicept’s commercial opportunity in IgAN is questionable due to the high degree of competition from KDNY, Otsuka, and Remegen. VERA ...
Summary Healthcare stocks have remained in vogue through volatile markets, driven by increased interest in the sector during COVID-19. During a painful year for equity investors in 2022, healthcare stocks offered a pocket of relative stability. Global healthcare stocks ended the yea...
News, Short Squeeze, Breakout and More Instantly...
SPDR Select Sector Fund - Health Care Company Name:
XLV Stock Symbol:
NYSE Market:
2024-07-09 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-29 11:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...